Abstract: This invention relates to the delivery of heterologous peptides or proteins such as therapeutic peptides, therapeutic proteins or antigens to mucosal sites using vesicles derived from the outer membrane of commensal bacteria, recombinant bacteria capable of producing such vesicles, and methods for the production of such vesicles. The invention further relates to an inducible expression system for use in recombinant bacteria.
Type:
Application
Filed:
May 10, 2021
Publication date:
September 2, 2021
Applicants:
QUADRAM INSTITUTE BIOSCIENCE, UEA ENTERPRISES LIMITED
Inventors:
REGIS GABRIEL STENTZ, SIMON RICHARD CARDING
Abstract: A method of identifying, monitoring and/or diagnosing mucosal bacterial presence or infection, said method including the step of detecting at least part of a sialic acid transporter protein encoded by Ruminococcus gnavus (R. gnavus) ATCC 29149 Nan cluster. In addition, a method of inhibition of the growth of bacterium, said method including the step of inhibition of a sialic acid transporter protein is included.
Type:
Application
Filed:
June 17, 2019
Publication date:
August 19, 2021
Applicant:
Quadram Institute Bioscience
Inventors:
Nathalie Juge, Andrew Bell, John Walshaw
Abstract: This invention relates to the delivery of heterologous peptides or proteins such as therapeutic peptides, therapeutic proteins or antigens to mucosal sites using vesicles derived from the outer membrane of commensal bacteria, recombinant bacteria capable of producing such vesicles, and methods for the production of such vesicles. The invention further relates to an inducible expression system for use in recombinant bacteria.
Type:
Grant
Filed:
April 28, 2017
Date of Patent:
May 11, 2021
Assignees:
QUADRAM INSTITUTE BIOSCIENCE, UEA ENTERPRISES LIMITED
Inventors:
Regis Gabriel Stentz, Simon Richard Carding